Zimmer Biomet signed the Global Health Equity Network’s Zero Health Gaps Pledge, a commitment from CEOs across industries and regions for their organizations to embed health equity in core strategies, operations and investments. Zimmer Biomet’s Health Equity division, established in 2023, has made meaningful strides on core areas of the 10-point pledge, including understanding the drivers of disparity in orthopaedic care, forging partnerships to collaborate on community-based solutions to reduce healthcare inequities, and establishing clear measures to track progress against short and long-term goals. Zimmer Biomet has a well-established legacy of addressing healthcare disparities through its philanthropic efforts, and now its Health Equity division has been working to integrate health equity goals into the company’s business strategy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ZBH:
- Zimmer Biomet price target lowered to $140 from $147 at Deutsche Bank
- Zimmer Biomet price target raised to $132 from $119 at Wells Fargo
- Citi opens ‘positive catalyst watch’ on Zimmer Biomet into AAOS
- Zimmer Biomet price target raised to $155 from $149 at Baird
- Zimmer Biomet sees FY24 adjusted EPS $8.00-$8.15, consensus $7.94